1. Home
  2. HALO vs CUBE Comparison

HALO vs CUBE Comparison

Compare HALO & CUBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • CUBE
  • Stock Information
  • Founded
  • HALO 1998
  • CUBE 2004
  • Country
  • HALO United States
  • CUBE United States
  • Employees
  • HALO N/A
  • CUBE N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • CUBE Real Estate Investment Trusts
  • Sector
  • HALO Health Care
  • CUBE Real Estate
  • Exchange
  • HALO Nasdaq
  • CUBE Nasdaq
  • Market Cap
  • HALO 7.4B
  • CUBE 9.7B
  • IPO Year
  • HALO N/A
  • CUBE 2004
  • Fundamental
  • Price
  • HALO $54.54
  • CUBE $41.29
  • Analyst Decision
  • HALO Buy
  • CUBE Buy
  • Analyst Count
  • HALO 9
  • CUBE 14
  • Target Price
  • HALO $63.56
  • CUBE $48.14
  • AVG Volume (30 Days)
  • HALO 3.3M
  • CUBE 2.0M
  • Earning Date
  • HALO 05-06-2025
  • CUBE 05-01-2025
  • Dividend Yield
  • HALO N/A
  • CUBE 5.04%
  • EPS Growth
  • HALO 55.40
  • CUBE N/A
  • EPS
  • HALO 3.76
  • CUBE 1.69
  • Revenue
  • HALO $1,084,306,000.00
  • CUBE $1,079,894,000.00
  • Revenue This Year
  • HALO $25.77
  • CUBE $1.99
  • Revenue Next Year
  • HALO $18.01
  • CUBE $3.76
  • P/E Ratio
  • HALO $14.51
  • CUBE $24.43
  • Revenue Growth
  • HALO 25.64
  • CUBE 1.89
  • 52 Week Low
  • HALO $42.01
  • CUBE $34.24
  • 52 Week High
  • HALO $70.51
  • CUBE $55.14
  • Technical
  • Relative Strength Index (RSI)
  • HALO 44.48
  • CUBE 47.34
  • Support Level
  • HALO $52.43
  • CUBE $40.68
  • Resistance Level
  • HALO $54.26
  • CUBE $43.91
  • Average True Range (ATR)
  • HALO 3.42
  • CUBE 0.85
  • MACD
  • HALO -0.49
  • CUBE -0.17
  • Stochastic Oscillator
  • HALO 30.60
  • CUBE 18.89

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About CUBE CubeSmart

CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Majority of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. The company derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.

Share on Social Networks: